Cervical screening in Western Kazakhstan: Liquid-based cytology 'Cell Scan' versus azur-eosin staining

被引:9
作者
Balmagambetova, Saule [1 ]
Gabutti, Giovanni [2 ]
Koyshybaev, Arip [1 ]
Martellucci, Cecilia Acuti [3 ]
Urazayev, Olzhas [1 ]
Sakiyeva, Kanshaiym [4 ]
Bekova, Karlygash [5 ]
机构
[1] West Kazakhstan Marat Ospanov Med Univ, Oncol Dept, 68 Maresyev St, Aktobe 030019, Kazakhstan
[2] Univ Ferrara, Dept Med Sci, Ferrara, Italy
[3] Univ Ferrara, Postgrad Sch Hyg & Prevent Med, Ferrara, Italy
[4] West Kazakhstan Marat Ospanov Med Univ, Obstetr & Gynaecol Dept, Aktobe, Kazakhstan
[5] West Kazakhstan Marat Ospanov Med Univ, Aktobe, Kazakhstan
关键词
Kazakhstan; cervical screening; cytology; 'Cell Scan' preservative fluids; azur-eosin staining; IMPLEMENTATION; PREVENTION; PROGRAM;
D O I
10.1177/0969141319885409
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To assess the effectiveness of the current cervical cancer screening tools in Western Kazakhstan. Methods Smears taken through (i) conventional cytology using azur-eosin staining and (ii) liquid-based cytology (LBC) 'Cell Scan' in the general female population and in women first diagnosed with cervical cancer were collected throughout the region. ROC-analysis with curve construction and weighted Cohen's kappa calculation were applied. A total of 494 cytological pairs were collected, including 94 sets with histology findings. Results The conventional (azur-eosin staining) technique contained 0.2% non-informative material and LBC 'Cell Scan' had 5.9%. Area under the curve was 0.95 for the conventional technique and 0.92 for 'Cell Scan' (p > 0.05). The conventional smears showed kappa 0.62, sensitivity 90.4% at specificity 90.0% for CIN2+, while LBC 'Cell Scan' smears showed kappa 0.47, sensitivity 83.3% at specificity 92.5%. Conclusions In this analysis it was not possible to prove that the LBC 'Cell Scan' technique was superior to its predecessor, azur-eosin staining. These findings highlight the need to modify the current screening programme according to updated international scientific evidence on effective screening design, such as the use of HPV DNA testing with Pap smear triage in women aged 30 or older. Further research, and a Health Technology Assessment, are necessary if we wish to establish a national standardized screening programme using the available technology appropriately.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 27 条
[1]  
Aimagambetova Gulzhanat, 2018, Asian Pac J Cancer Prev, V19, P1175, DOI 10.22034/APJCP.2018.19.5.1175
[2]  
[Anonymous], 2016, INT HPV TEST CERV CA
[3]  
[Anonymous], 2011, POP SCREEN CERV CANC
[4]   Secondary prevention of cervical cancer [J].
Basu, Partha ;
Mittal, Srabani ;
Vale, Diama Bhadra ;
Chami Kharaji, Youssef .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2018, 47 :73-85
[5]  
BOARDMAN CH, 2019, CERVICAL CANC GUIDEL
[6]  
BRUNI L, HUM PAP REL DIS KAZ
[7]  
Cancer Council Australia Cervical Cancer Screening Guidelines Working Party, 2016, NAT CERV SCREEN PROG
[8]   NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA Focused Rescreening Prior to Report Issuance, An Enhanced Quality Control Measure [J].
Cormier, Karen ;
Schaaf, Michael ;
Hamilton, Stephanie ;
Tickman, Ronald J. ;
Perez-Reyes, Nuria ;
Sturgis, Charles D. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (04) :494-500
[9]   Key indicators of organized cancer screening programs: Results from a Delphi study [J].
Csanadi, Marcell ;
de Kok, Inge M. C. M. ;
Heijnsdijk, Eveline A. M. ;
Anttila, Ahti ;
Heinavaara, Sirpa ;
Pitter, Janos G. ;
Szeles, Gyorgy ;
Ivanus, Urska ;
Priaulx, Jennifer ;
Veerus, Piret ;
Senore, Carlo ;
de Koning, Harry J. ;
Voko, Zoltan .
JOURNAL OF MEDICAL SCREENING, 2019, 26 (03) :120-126
[10]   Worldwide burden of cancer attributable to HPV by site, country and HPV type [J].
de Martel, Catherine ;
Plummer, Martyn ;
Vignat, Jerome ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) :664-670